Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nkarta Inc (NKTX)

Nkarta Inc (NKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 124,177
  • Shares Outstanding, K 70,958
  • Annual Sales, $ 0 K
  • Annual Income, $ -108,790 K
  • EBIT $ -132 M
  • EBITDA $ -130 M
  • 60-Month Beta 0.81
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.33

Options Overview Details

View History
  • Implied Volatility 175.94% ( +104.36%)
  • Historical Volatility 84.42%
  • IV Percentile 81%
  • IV Rank 22.73%
  • IV High 636.43% on 01/06/25
  • IV Low 40.45% on 06/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 111
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 2,815
  • Open Int (30-Day) 4,925

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.37
  • Number of Estimates 5
  • High Estimate -0.25
  • Low Estimate -0.50
  • Prior Year -0.34
  • Growth Rate Est. (year over year) -8.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6600 +5.42%
on 05/22/25
2.2100 -20.81%
on 04/24/25
-0.4300 (-19.72%)
since 04/23/25
3-Month
1.3100 +33.59%
on 03/26/25
2.3400 -25.21%
on 03/27/25
-0.3000 (-14.63%)
since 02/21/25
52-Week
1.3100 +33.59%
on 03/26/25
8.2300 -78.74%
on 07/16/24
-4.7900 (-73.24%)
since 05/23/24

Most Recent Stories

More News
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights

NKTX : 1.7500 (-0.85%)
Nkarta to Participate in an April Investor Conference

NKTX : 1.7500 (-0.85%)
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights

NKTX : 1.7500 (-0.85%)
Nkarta to Participate in March Investor Conferences

NKTX : 1.7500 (-0.85%)
Nkarta, Inc. Opens Enrollment for Ntrust-2 Trial Evaluating NKX019 in Multiple Autoimmune Diseases

Nkarta opens Ntrust-2 trial for NKX019 in systemic sclerosis, myositis, and vasculitis; myasthenia gravis trial also initiated.Quiver AI SummaryNkarta, Inc. has announced the opening of patient enrollment...

NKTX : 1.7500 (-0.85%)
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2

NKTX : 1.7500 (-0.85%)
Nkarta to Participate in an Upcoming Investor Conference

NKTX : 1.7500 (-0.85%)
Nkarta to Participate in an Upcoming Investor Conference

NKTX : 1.7500 (-0.85%)
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights

NKTX : 1.7500 (-0.85%)
Why Nkarta Stock Is Soaring Today

One analyst is now more bullish about this clinical-stage biotech stock.

NKTX : 1.7500 (-0.85%)
RJF : 145.32 (-0.79%)

Business Summary

Nkarta Inc. is a biopharmaceutical company. It develops and commercializes cell therapies for cancer treatment. The company's product candidate includes NKX101 and NKX019, which are in clinical stage. Nkarta Inc. is based in South San Francisco, California.

See More

Key Turning Points

3rd Resistance Point 1.8367
2nd Resistance Point 1.8033
1st Resistance Point 1.7767
Last Price 1.7500
1st Support Level 1.7167
2nd Support Level 1.6833
3rd Support Level 1.6567

See More

52-Week High 8.2300
Fibonacci 61.8% 5.5866
Fibonacci 50% 4.7700
Fibonacci 38.2% 3.9534
Last Price 1.7500
52-Week Low 1.3100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar